LP352 (bexicaserin) Placebo Oral Solution, Bexicaserin
LP352-303
Phase 3 small_molecule active
Quick answer
LP352 (bexicaserin) Placebo Oral Solution, Bexicaserin for Developmental and Epileptic Encephalopathies (DEEs) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Developmental and Epileptic Encephalopathies (DEEs)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active